Copyright
©The Author(s) 2015.
World J Crit Care Med. May 4, 2015; 4(2): 139-151
Published online May 4, 2015. doi: 10.5492/wjccm.v4.i2.139
Published online May 4, 2015. doi: 10.5492/wjccm.v4.i2.139
Table 11 Pharmacokinetic and physicochemical properties of drugs commonly used in the intensive care units1
Indication/class | Specific drug | LogP | Pb (%) | Vd (L/kg) |
Sedative | ||||
Propofol | 4.16 | 98 | 60 | |
Midazolam | 3.33 | 97 | 2 | |
Lorazepam | 3.53 | 91 | 1.3 | |
Dexmedetomidine | 3.39 | 94 | 1.3 | |
Analgesic | ||||
Morphine | 0.9 | 35 | 3 | |
Fentanyl | 3.82 | 83 | 5 | |
Hydromorphone | 1.62 | 20 | 1.2 | |
Delirium | ||||
Quetiapine | 2.81 | 83 | 10 | |
Haloperidol | 3.66 | 92 | 18 | |
Antiarrhythmic | ||||
Diltiazem | 2.37 | 80 | 5 | |
Amiodarone | 7.64 | 98 | 70 | |
Digoxin | 2.37 | 25 | 6 | |
Antihypertensive | ||||
Labetalol | 1.89 | 50 | 5 | |
Esmolol | 1.82 | 55 | 3 | |
Hydralazine | 0.75 | 87 | 4 | |
GI/antiemetic | ||||
Pantoprazole | 2.18 | 98 | 0.15 | |
Famotidine | -2 | 18 | 1.2 | |
Ondansetron | 2.35 | 73 | 2 | |
Metoclopramide | 1.4 | 30 | 4.4 | |
Erythromycin | 2.6 | 85 | 0.6 | |
Anticoagulant | ||||
Enoxaparin | -8.3 | 80 | 0.07 | |
Heparin | NA | NA | 0.05 | |
Fondaparinux | -10 | 94 | 0.1 | |
Argatroban | -0.97 | 54 | 0.17 | |
Corticosteroid | ||||
Methylprednisolone | 1.56 | 78 | 1.1 | |
Hydrocortisone | 1.28 | 95 | 0.5 | |
Antifungal/antiviral | ||||
Voriconazole | 1.82 | 58 | 3 | |
Fluconazole | 0.56 | 11 | 0.8 | |
Micafungin | -6.3 | 99 | 0.39 | |
Amphotericin | -2.3 | 95 | 1.8 | |
Acyclovir | -1 | 9-33 | 0.6 | |
Antibiotic | ||||
Azithromycin | 2.44 | 51 | 0.44 | |
Aztreonam | -3.1 | 56 | 0.17 | |
Cefazolin | -1.5 | 80 | 0.14 | |
Cefepime | -4.3 | 20 | 0.23 | |
Cefoxitin | 0.29 | 75 | 0.26 | |
Ceftriaxone | -1.8 | 95 | 0.14 | |
Ciprofloxacin | -0.81 | 35 | 2.5 | |
Clindamycin | 1.04 | 93 | 2.5 | |
Linezolid | 0.64 | 31 | 0.64 | |
Meropenem | -4.4 | 2 | 0.36 | |
Metronidazole | -0.46 | 25 | 1 | |
Moxifloxacin | -0.5 | 50 | 2 | |
Piperacillin/tazobactam | -0.26 | 0.1 | ||
Vancomycin | -3.1 | 55 | 0.7 | |
Anti-seizure | ||||
Levetiracetam | -0.59 | 8 | 0.6 | |
Phenytoin | 2.15 | 90 | 0.7 |
- Citation: Erstad BL. Designing drug regimens for special intensive care unit populations. World J Crit Care Med 2015; 4(2): 139-151
- URL: https://www.wjgnet.com/2220-3141/full/v4/i2/139.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v4.i2.139